Galenica Sante AG (GALE) - Total Liabilities

Latest as of December 2025: CHF1.86 Billion CHF ≈ $2.35 Billion USD

Based on the latest financial reports, Galenica Sante AG (GALE) has total liabilities worth CHF1.86 Billion CHF (≈ $2.35 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Galenica Sante AG (GALE) investment intensity to see how much of total assets are deployed in long-term investments.

Galenica Sante AG - Total Liabilities Trend (2013–2025)

This chart illustrates how Galenica Sante AG's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Galenica Sante AG assets under control.

Galenica Sante AG Competitors by Total Liabilities

The table below lists competitors of Galenica Sante AG ranked by their total liabilities.

Company	Country	Total Liabilities
Acm Research Inc NASDAQ:ACMR	USA	$982.43 Million
Adecco Group AG Class N SW:ADEN	Switzerland	CHF8.94 Billion
Persimmon Plc F:OHP	Germany	€1.70 Billion
ESAB Corp NYSE:ESAB	USA	$3.39 Billion
Hamilton Lane Inc NASDAQ:HLNE	USA	$844.76 Million
Premier Inc NASDAQ:PINC	USA	$1.52 Billion
Emcure Pharmaceuticals Ltd NSE:EMCURE	India	Rs46.36 Billion
PBF Energy Inc NYSE:PBF	USA	$7.68 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Galenica Sante AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Galenica Sante AG net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.15	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.12	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.25	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.56	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Galenica Sante AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Galenica Sante AG (2013–2025)

The table below shows the annual total liabilities of Galenica Sante AG from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	CHF1.86 Billion ≈ $2.35 Billion	+22.41%
2024-12-31	CHF1.52 Billion ≈ $1.92 Billion	+0.22%
2023-12-31	CHF1.52 Billion ≈ $1.92 Billion	+7.18%
2022-12-31	CHF1.41 Billion ≈ $1.79 Billion	+2.33%
2021-12-31	CHF1.38 Billion ≈ $1.75 Billion	+14.64%
2020-12-31	CHF1.21 Billion ≈ $1.52 Billion	-0.37%
2019-12-31	CHF1.21 Billion ≈ $1.53 Billion	+30.60%
2018-12-31	CHF926.49 Million ≈ $1.17 Billion	-1.09%
2017-12-31	CHF936.67 Million ≈ $1.18 Billion	-43.28%
2016-12-31	CHF1.65 Billion ≈ $2.09 Billion	+12.07%
2015-12-31	CHF1.47 Billion ≈ $1.86 Billion	+0.33%
2014-12-31	CHF1.47 Billion ≈ $1.86 Billion	-2.49%
2013-12-31	CHF1.51 Billion ≈ $1.90 Billion	--

About Galenica Sante AG

SW:GALE Switzerland Medical Distribution

Market Cap

$5.20 Billion

CHF4.11 Billion CHF

Market Cap Rank

#4051 Global

#61 in Switzerland

Share Price

CHF82.50

Change (1 day)

-1.08%

52-Week Range

CHF80.45 - CHF102.80

All Time High

CHF102.80